The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Methylation, mutation and cancer
Abstract
The fifth base in human DNA, 5‐methylcytosine, is inherently mutagenic. This has led to marked changes in the distribution of the CpG methyl acceptor site and an 80% depletion in its frequency of occurrence in vertebrate DNA. The coding regions of many genes contain CpGs which are methylated in sperm and serve as hot spots for mutation in human genetic diseases. Fully 30–40% of all human germline point mutations are thought to be methylation induced even though the CpG dinucleotide is under‐represented and efficient cellular repair systems exist. Importantly, tumor suppressor genes such as p53 also contain methylated CpGs and these serve as hot spots for mutations in some, but not all, human cancers. Comparison of the spectrum of mutations present in this gene in different human cancers allows for predictions to be made on the molecular mechanisms of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
Cited by
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
The essentials of DNA methylation
Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90526-i · Cited by 948
TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
Petitjean, A., Achatz, M. I. W., Borresen-Dale, A. L., Hainaut, P., & Olivier, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210302 · Cited by 884
Valinluck, V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh739 · Cited by 756
Suppression of intestinal neoplasia by DNA hypomethylation
Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Edward Jung, W., Li, E., Weinberg, R. A., & Jaenisch, R. (1995) · Cell · doi:10.1016/0092-8674(95)90329-1 · Cited by 710
The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites
Hendrich, B., Hardeland, U., Ng, H.-H., Jiricny, J., & Bird, A. (1999) · Nature · doi:10.1038/45843 · Cited by 637
The molecular biology of cancer
Bertram, J. S. (2000) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(00)00007-8 · Cited by 585
Folate and carcinogenesis: evidence, mechanisms, and implications
Kim, Y. (1999) · The Journal of Nutritional Biochemistry · doi:10.1016/s0955-2863(98)00074-6 · Cited by 554
THE ROLE OF DNA METHYLATION IN CANCER GENETICS AND EPIGENETICS
Laird, P. W., & Jaenisch, R. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.441 · Cited by 472
The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA
Shen, J.-C., Rideout, W. M., & Jones, P. A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.6.972 · Cited by 457
Self-citationReyna-López, G. E., Simpson, J., & Ruiz-Herrera, J. (1997) · Molecular and General Genetics MGG · doi:10.1007/s004380050374 · Cited by 431
Skinner, M. K. (2015) · Genome Biology and Evolution · doi:10.1093/gbe/evv073 · Cited by 342
Cytosine methylation determines hot spots of DNA damage in the human P 53 gene
Denissenko, M. F., Chen, J. X., Tang, M.-S., & Pfeifer, G. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3893 · Cited by 339
Kim, Y., Pogribny, I., Basnakian, A., Miller, J., Selhub, J., James, S., & Mason, J. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.1.46 · Cited by 326
Karlin, S., Doerfler, W., & Cardon, L. R. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.2889-2897.1994 · Cited by 326
Zingg, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.869 · Cited by 321
Bacterial CpG DNA Activates Immune Cells to Signal Infectious Danger
Wagner, H. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60790-7 · Cited by 314
Large-scale human promoter mapping using CpG islands
Ioshikhes, I. P., & Zhang, M. Q. (2000) · Nature Genetics · doi:10.1038/79189 · Cited by 309
Evolutionary Basis of Codon Usage and Nucleotide Composition Bias in Vertebrate DNA Viruses
Shackelton, L. A., Parrish, C. R., & Holmes, E. C. (2006) · Journal of Molecular Evolution · doi:10.1007/s00239-005-0221-1 · Cited by 307
DNA methyltransferase inhibitors—state of the art
Goffin, J., & Eisenhauer, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf314 · Cited by 283
Drost, J. B., & Lee, W. R. (1995) · Environmental and Molecular Mutagenesis · doi:10.1002/em.2850250609 · Cited by 263
High frequency mutagenesis by a DNA methyltransferase
Shen, J.-C., Rideout, W. M., & Jones, P. A. (1992) · Cell · doi:10.1016/s0092-8674(05)80057-1 · Cited by 262
Self-citationMutagenesis at Methylated CpG Sequences
Pfeifer, G. P. (2006) · Current Topics in Microbiology and Immunology · doi:10.1007/3-540-31390-7_10 · Cited by 262
Poulos, R. C., Olivier, J., & Wong, J. W. H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx463 · Cited by 93
Metadata
- Authors
- Jones, P. A., Rideout, W. M., Shen, J., Spruck, C. H., & Tsai, Y. C.
- Venue
- BioEssays
- Publisher
- Wiley
- Published
- 1992-01
- Volume
- 14
- Issue
- 1
- Pages
- 33-36
- ISSN
- 0265-9247 (ISSN-L)
- 1521-1878
- OpenAlex
- W2040685858
- Cited by
- 202
- References
- 1
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.